Home » Authors » Anette Breindl

Articles by Anette Breindl

Cutting Off TB's Energy Source Might Be Novel Line Of Attack

Dec. 15, 2004

By Anette Breindl

Broadening Immune System's Horizon For New HIV Defenses

Dec. 13, 2004

By Anette Breindl

Broadening Immune System's Horizon For New HIV Defenses

Dec. 13, 2004

By Anette Breindl

Putting Nobel Prize-Winning Proteasome Research To Use

Dec. 10, 2004

By Anette Breindl

Putting Nobel Prize-Winning Proteasome Research To Use

Dec. 10, 2004

By Anette Breindl

Reduced Specificity Key To Fighting Gleevec Resistance?

Dec. 9, 2004

By Anette Breindl

Reduced Specificity Key To Fighting Gleevec Resistance?

Dec. 9, 2004

By Anette Breindl

For Once, Selective Pressure Leads To Nonfunctional Gene

Dec. 3, 2004

By Anette Breindl

For Once, Selective Pressure Leads To Nonfunctional Gene

Dec. 3, 2004

By Anette Breindl

Antimetastatic Antibodies In Immunological 'Fossil Record'

Dec. 1, 2004

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...